Phosphorylation of the HTLV-1 matrix L-domain-containing protein by virus-associated ERK-2 kinase

Virology

Volumn 349, Issue 2, 2006, Pages 430-439

  Hémonnot, Bénédicte ^a   Molle, Dorothée ^a   Bardy, Martine ^a   Gay, Bernard ^a   Laune, Daniel ^a   Devaux, Christian ^a   Briant, Laurence ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Budding; ERK 2; HTLV 1; L domain; Phosphorylation

Indexed keywords

ALANINE; AMINO ACID DERIVATIVE; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BAY REGION BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; RETROVIRUS; SEQUENCE HOMOLOGY; VIROGENESIS; VIRUS INFECTIVITY; VIRUS PARTICLE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL LINE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; SERINE; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33646858158     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.02.043     Document Type: Article

References (43)

1. Blot V., Perugi F., Gay B., Prevost M.C., Briant L., Tangy F., Abriel H., Staub O., Dokhelar M.C., and Pique C. Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J. Cell Sci. 117 (2004) 2357-2367
2. Bouamr F., Melillo J.A., Wang M.Q., Nagashima K., de Los Santos M., Rein A., and Goff S.P. PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J. Virol. 77 22 (2003) 11882-11895
3. Bradac J., and Hunter E. Polypeptides of Mason-Pfizer monkey virus: I. Synthesis and processing of the gag-gene products. Virology 138 2 (1984) 260-275
4. Cartier C., Deckert M., Grangeasse C., Trauger R., Jensen F., Bernard A., Cozzone A., Desgranges C., and Boyer V. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles. J. Virol. 71 (1997) 4832-4837
5. Cartier C., Hemonnot B., Gay B., Bardy M., Sanchiz C., Devaux C., and Briant L. Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein. J. Biol. Chem. 278 37 (2003) 35211-35219
6. Craven R.C., Harty R.N., Paragas J., Palese P., and Wills J.W. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J. Virol. 73 4 (1999) 3359-3365
7. Demirov D.G., and Freed E.O. Retrovirus budding. Virus Res. 106 2 (2004) 87-102
8. Derse D., Mikovits J., Polianova M., Felber B.K., and Ruscetti F. Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells. J. Virol. 69 3 (1995) 1907-1912
9. Dettenhofer M., and Yu X.F. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73 2 (1999) 1460-1467
10. Garnier L., Ratner L., Rovinski B., Cao S.X., and Wills J.W. Particle size determinants in the human immunodeficiency virus type 1 Gag protein. J. Virol. 72 6 (1998) 4667-4677
11. Hémonnot B., Cartier C., Gay B., Rebuffat S., Bardy M., Devaux C., Boyer V., and Briant L. The host cell MAPKinase ERK2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1. J. Biol. Chem. 279 31 (2004) 32426-32434
12. Henderson L.E., Sowder R., Smythers G., Benveniste R.E., and Oroszlan S. Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus. J. Virol. 55 3 (1985) 778-787
13. Hicke L. Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol. 9 3 (1999) 107-112
14. Huang M., Orenstein J.M., Martin M.A., and Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69 11 (1995) 6810-6818
15. Hui E.K. Virion-associated protein kinases. Cell. Mol. Life Sci. 59 6 (2002) 920-931
16. Jacque J.M., Mann A., Enslen H., Sharova N., Brichacek B., Davis R.J., and Stevenson M. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17 9 (1998) 2607-2618
17. Kikonyogo A., Bouamr F., Vana M.L., Xiang Y., Aiyar A., Carter C., and Leis J. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. U.S.A. 98 20 (2001) 11199-11204
18. Le Blanc I., Prevost M.C., Dokhelar M.C., and Rosenberg A.R. The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process. J. Virol. 76 19 (2002) 10024-10029
19. Lu P.J., Zhou X.Z., Shen M., and Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283 5406 (1999) 1325-1328
20. Martin-Serrano J., Zang T., and Bieniasz P.D. Role of ESCRT-I in retroviral budding. J. Virol. 77 8 (2003) 4794-4804
21. Morris D.P., and Greenleaf A.L. The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 275 51 (2000) 39935-39943
22. Morris D.P., Phatnani H.P., and Greenleaf A.L. Phospho-carboxyl-terminal domain binding and the role of a prolyl isomerase in pre-mRNA 3′-End formation. J. Biol. Chem. 274 44 (1999) 31583-31587
23. Muller B., Patschinsky T., and Krausslich H.G. The Late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles. J. Virol. 76 3 (2002) 1015-1024
24. Naso R.B., Karshin W.L., Wu Y.H., and Arlinghaus R.B. Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products. J. Virol. 32 1 (1979) 187-198
25. Ott D.E., Coren L.V., Copeland T.D., Kane B.P., Johnson D.G., Sowder II R.C., Yoshinaka Y., Oroszlan S., Arthur L.O., and Henderson L.E. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. J. Virol. 72 4 (1998) 2962-2968
26. Ott D.E., Coren L.V., Johnson D.G., Kane B.P., Sowder II R.C., Kim Y.D., Fisher R.J., Zhou X.Z., Lu K.P., and Henderson L.E. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 266 1 (2000) 42-51
27. Ott D.E., Coren L.V., Sowder II R.C., Adams J., Nagashima K., and Schubert U. Equine infectious anemia virus and the ubiquitin-proteasome system. J. Virol. 76 6 (2002) 3038-3044
28. Parent L.J., Bennett R.P., Craven R.C., Nelle T.D., Krishna N.K., Bowzard J.B., Wilson C.B., Puffer B.A., Montelaro R.C., and Wills J.W. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69 9 (1995) 5455-5460
29. Patnaik A., Chau V., and Wills J.W. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. U.S.A. 97 24 (2000) 13069-13074
30. Puffer B.A., Parent L.J., Wills J.W., and Montelaro R.C. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71 9 (1997) 6541-6546
31. Schubert U., Ott D.E., Chertova E.N., Welker R., Tessmer U., Princiotta M.F., Bennink J.R., Krausslich H.G., and Yewdell J.W. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U.S.A. 97 24 (2000) 13057-13062
32. Sen A., Sherr C.J., and Todaro G.J. Specific binding of the type C viral core protein p12 with purified viral RNA. Cell 7 1 (1976) 21-32
33. Sen A., Sherr C.J., and Todaro G.J. Phosphorylation of murine type C viral p12 proteins regulates their extent of binding to the homologous viral RNA. Cell 10 3 (1977) 489-496
34. Strack B., Calistri A., Accola M.A., Palu G., and Gottlinger H.G. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. U.S.A. 97 24 (2000) 13063-13068
35. Strack B., Calistri A., Craig S., Popova E., and Gottlinger H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114 6 (2003) 689-699
36. Sudol M., and Hunter T. New wrinkles for an old domain. Cell 103 7 (2000) 1001-1004
37. Verdecia M.A., Bowman M.E., Lu K.P., Hunter T., and Noel J.P. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat. Struct. Biol. 7 8 (2000) 639-643
38. Vogt V.M. Ubiquitin in retrovirus assembly: actor or bystander?. Proc. Natl. Acad. Sci. U.S.A. 97 24 (2000) 12945-12947
39. Wang H., Machesky N.J., and Mansky L.M. Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release. J. Virol. 78 3 (2004) 1503-1512
40. Yasuda J., and Hunter E. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J. Virol. 72 5 (1998) 4095-4103
41. Yoshinaka Y., and Luftig R.B. In vitro phosphorylation of murine leukemia virus proteins: specific phosphorylation of Pr65gag, the precursor of the internal core antigens. Virology 116 1 (1982) 181-195
42. Yuan B., Campbell S., Bacharach E., Rein A., and Goff S.P. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J. Virol. 74 16 (2000) 7250-7260
43. Yueh A., and Goff S.P. Phosphorylated serine residues and an arginine-rich domain of the moloney murine leukemia virus p12 protein are required for early events of viral infection. J. Virol. 77 3 (2003) 1820-1829